Healthy women Astraxanthin natural oil vitamin E vitamin D3 facial skin
Conditions
Interventions
Experimental Dietary Supplement,Placebo Comparator No treatment
Astraxanthin , Natural plant-based oil , vitamin E , vitamin D3,Medium-chain triglyceride
Ingredients per softgel
Haematococcus pluvialis Oleoresin 50 mg
Flaxseed oil 139.4 mg
Borage oil 132 mg
Perilla oil 43 mg
Avocado oil 38 mg
Wheat germ oil 27 mg
Virgin Coconut oil 23.45 mg
Grape seed
Sponsors
Prevent U company limited
Eligibility
Sex/Gender
Female
Age
35 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. female 2. age 35-45 years 3. General good health and mental condition , no evidence of underlying disease 4. regular menstrual cycles 5. Person who agrees to participate in the study and has affixed her signature in the written consent to participate in the study. 6. Person without history of Carotenoids and Astaxanthin hypersensitivity 7. Person without skin diseases, eczema and inflammation at the areas to be measured. 8. Person who had not received any medical operation for skin treatment on the areas to be measured such as exfoliation, iontophoresis and radiofrequency within one month prior to participating in the study. 9. Person who had not injected with Botulinum toxin at the areas to be measured within 8 months prior to participating in the study. 10. Person who had not injected with any fillers at the areas to be measured within 1 year prior to participating in the study. 11. Non-smoker 12. Person who does not live a lifestyle that is exposed to intense heat and sunlight for many hours a day without protection. 13. Person who is not pregnant or breastfeeding
Exclusion criteria
Exclusion criteria: 1. Expressing their intention to drop out or have reasons to drop out. 2. Became pregnant during the study period. 3. Experiencing adverse reactions, side effects or allergic reactions while taking the supplement tested. 4. Forgetting to take any supplement or placebo given for more than 2 consecutive days or more 2 days a week or more than 4 days a month. 5. Undergoing any medical procedure such as Botulinum toxin injection, filler injection, and laser treatment during the test. 6. Changes in skin and health care behaviors during the study period such as taking other drugs or dietary supplements, applying additional moisturizer or cream or stopping the skin care routine during the test. 7. Experiencing skin disease, allergic rash, severe inflammation at the measured areas.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin elasticity at 8 weeks after the intervention cutometer dual MPA580,skin hydration at 8 weeks after the intervention cutometer dual MPA580 ( corneometer ),transepidermal water loss at 8 weeks after the intervention cutometer dual MPA580 ( tewameter ),pigmentation at 8 weeks after the intervention cutometer dual MPA580 ( mexameter ),wrinkles at 8 weeks after the intervention VISIA 7th generation | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Countries
Thailand
Contacts
Public ContactSararin Pranonsatid
Dhurakij pundit university
Outcome results
None listed